Watson Pharmaceuticals (NYSE:WPI) received approval from the U.S. Food and Drug Administration for its generic version of a drug to treat C. difficile. Watson submitted an abbreviated new drug application for vancomycin hydrochloride capsules, USP, in 125 mg and 250 mg doses, used to treat diarrhea caused by C. difficile and for the treatment of […]
Watson Pharmaceuticals (NYSE:WPI) faces a delay in the approval of a vaginal gel that addresses high-risk pregnancies because it received a complete response letter from U.S. regulators. The letter from the U.S. Food and Drug Administration said the results of phase 3 clinical trial for progesterone vaginal gel 8% did not meet the level of […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Watson Pharmaceuticals (NYSE:WPI) wants to add a branded drugs focus alongside its generics business and is setting aside $6 billion for acquisitions to do it, according to a report by Bloomberg. Chief executive officer Paul Bisaro said: “Everything we need to be a branded pharma company we have, except for the sales force. … And […]
Watson Pharmaceuticals (NYSE:WPI) has said it will build a $4.5 million research and development facility focused on developing respiratory products and inhalation technology in New Jersey. The drugmaker does not currently have a respiratory or inhalation platform, “so we will be establishing that organically,” a spokeswoman for the company said. About 50 new and current […]
A U.S. Food and Drug Administration panel has voted against Columbia Laboratories‘ (Nasdaq: CBRX) and Watson Pharmaceuticals’ (NYSE: WPI) progesterone vaginal gel 8% to reduce preterm birth in women, saying the panel requires more information. The Advisory Committee for Reproductive Health Drugs said the gel did not produce a statistically significant reduction in preterm births […]
Watson Pharmaceuticals (NYSE:WPI) has launched its generic version of Pfizer’s (NYSE:PFE) blockbuster cholesterol drug Lipitor, as part of an agreement for what it calls the largest generic drug launch in U.S. history. The launch of the generic Lipitor follows the end of Pfizer’s exclusive patent on the drug, but how much market share it will […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Watson Pharmaceuticals‘ (NYSE:WPI) subsidiary Watson Laboratories has received approval form the U.S. Food and Drug Administration for its generic version of Bayer‘s Yaz oral contraceptive. Vestura is also approved to treat mild acne for women ages 14 years or older, but only if it is also being used as an oral contraceptive, according to the […]
Watson Pharmaceuticals (NYSE:WPI) got approval from the U.S. Food and Drug Administration for its abbreviated new drug application for morphine sulfate extended-release capsules, the generic version of Actavis‘ Kadian, according to a statement from the company. The drug manages moderate to severe prolonged pain. For the year ending Sept. 30, Kadian had about $275 million […]
Antares Pharma product sales soared 41 percent in the first nine months of 2011 to $5.8 million, helped in part by customers Teva (NASDAQ: TEVA) and Ferring Pharmaceutical. The Ewing, New Jersey company focuses on needle-free self-injection pharmaceutical products and topical gel-based medicines and partners with larger companies such as Teva and Watson Pharmaceuticals (NYSE: […]
Watson Pharmaceuticals’ (NYSE:WPI) strategy for launching its generic version of Lipitor was the topic of conversation in its third-quarter results as Pfizer’s (NYSE:PFE) exclusive patent to the cholesterol drug nears its expiration date. During Watson’s conference call to discuss its quarterly earnings, CEO Paul Bisaro said: “Regarding the launch of generic Lipitor later this month, […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Highlights of the important and the interesting from the world of healthcare: What happens when a human gets infected by computer virus? A British scientist claims to be the first human “infected” by a computer virus, an experiment he hopes will aid research into the risks associated with implanted electronic medical devices. The scientist deliberately […]
Highlights of the important and the interesting from the world of healthcare: Finally! Some good pharma news: Amid what seems like an endless cascade of merger-inspired Big Pharma layoffs, one bright spot has emerged. Generic drugmaker Watson Pharmaceutics plans to double to 500 its employees in New Jersey over the next few years. It may […]
Generic drugmaker Mylan Pharmaceuticals Inc. has received FDA approval to begin shipping a generic version of a drug that treats gallstones. Ursodial USP is the generic version of Watson Pharmaceuticals’ Actigall capsules. A number of other drugmakers sell Ursodial capsules, including Lannett Company and Teva Pharmaceuticals. Ursodia USP is a bile acid that naturally occurs […]